• 제목/요약/키워드: Cancer metastasis

검색결과 2,595건 처리시간 0.034초

선행화학요법으로 원격전이의 관해 후 위절제를 시행한 원격전이를 동반한 위암 1예 (A Case of Advanced Gastric Cancer with Virchow's Node and Lung Metastasis Successfully Resected after Combined Chemotherapy of Taxotere, CDDP, and 5-FU)

  • 김두원;서병조;유항종;김준희;이혜경;김진복
    • Journal of Gastric Cancer
    • /
    • 제4권4호
    • /
    • pp.282-285
    • /
    • 2004
  • 전 세계적으로 위암의 발생빈도와 사망률은 감소하고 있으나 우리나라에서는 가장 흔한 암르로 중요한 사망 원인 중 하나이다. 특히, 진행성 위암의 경우에는 아직도 예후가 불랴하며 예후에 dudgiddf 미치는 인자로는 원격전이, 림프절 전이, 불완전한 수술절제 등이 있다. 선행화학요법은 수술 전에 화학요법을 시행하여 종양의 크기를 줄인 다음 수술을 시행하는 방법으로 이는 절제 불가능한 진행성 위암에서 병소의 국소적인 종양을 감소시켜 절제율이 증가하는 경우는 많이 있었다. 그러나 혈행성 및 복막파종 등 가종 원격전이를 동반한 위암에서의 선행화학요법에 대한 연구는 아직 부족한 실정이다. 이에 본원에서 폐전이 및 좌측 쇄골상부 림프절 전이가 있는 환자에서 선행화학요법 시행 후 원격전이 부위의 완전 관해 후 위전절제술을 시행 후 원격전이 부위의 완전 관해 후 위전절제술을 시행한 1예를 문헌 고찰과 함께 보고하는 바이다. 증례: 47세 여자환자로 이학적 검사상 좌측 쇄골상부 림프절이 만져지고 흉부 방산선 소견 상 다발성 폐전이를 동반한 진행성 위암으로 진단 받았다. 술 전 항암요법으로서 Taxotere, CDDP와 5-FU를 투여하였다. 항암화학요범 4회 실시 후 좌측 쇄골상부 림프절과 흉부 방산선 소견 상 보이던 다발성 폐전이가 사라졌고, 복부 CT 소견 상 위병 변의 크기의 감소를 보였다. 이에 저자들은 위전절제술과 D2 림프절 곽청술을 시행하였다. 병리조직검사상 위암은 위근육층까지 도달했으며 62개의 절제된 림프절 중 42개에서 암세포가 발견되었다. 환자는 수술 후 2회의 항암요법을 추가로 시행 받은 후 퇴원하였다.

  • PDF

Epithelial-Mesenchymal Transition-Inducing Factors Involved in the Progression of Lung Cancers

  • Nam, Min-Woo;Kim, Cho-Won;Choi, Kyung-Chul
    • Biomolecules & Therapeutics
    • /
    • 제30권3호
    • /
    • pp.213-220
    • /
    • 2022
  • Although there have been advances in cancer therapy and surgical improvement, lung cancer has the lowest survival rate (19%) at all stages. This is because most patients are diagnosed with concurrent metastasis, which occurs due to numerous related reasons. Especially, lung cancer is one of the most common and malignant cancers in the world. Although there are advanced therapeutic strategies, lung cancer remains one of the main causes of cancer death. Recent work has proposed that epithelial-mesenchymal transition (EMT) is the main cause of metastasis in most cases of human cancers including lung cancer. EMT involves the conversion of epithelial cells, wherein the cells lose their epithelial abilities and become mesenchymal cells involved in embryonic development, such as gastrulation and neural crest formation. In addition, recent research has indicated that EMT contributes to altering the cancer cells into cancer stem cells (CSCs). Although EMT is important in the developmental stages, this process also activates lung cancer progression, including complicated and diverse signaling pathways. Despite the numerous investigations on signaling pathways involved in the progression of lung cancer, this malignancy is considered critical for treatment. EMT in lung cancer involves many transcription factors and inducers, for example, Snail, TWIST, and ZEB are the master regulators of EMT. EMT-related factors and signaling pathways are involved in the progression of lung cancer, proposing new approaches to lung cancer therapy. In the current review, we highlight the signaling pathways implicated in lung cancer and elucidate the correlation of these pathways, indicating new insights to treat lung cancer and other malignancies.

Inhibitory effect of Erythronium japonicum on the human breast cancer cell metastasis

  • You, Mi-Kyoung;Kim, Min-Sook;Rhyu, Jin;Bang, Mi-Ae;Kim, Hyeon-A
    • Nutrition Research and Practice
    • /
    • 제9권1호
    • /
    • pp.17-21
    • /
    • 2015
  • BACKGROUND/OBJECTIVES: In this study, the inhibitory effect of Erythronium japonicum extracts on the metastasis of MDA-MB-231 human breast cancer cell line was determined. MATERIALS/METHODS: Cells were cultured with DMSO or with 50, 75, 100 or $250{\mu}g/ml$ of Erythronium japonicum methanol or ethanol extract. RESULTS: Both methanol and ethanol extracts significantly inhibited the growth and induced apoptosis of MDA-MB-231 cells in a dose-dependent manner. Erythronium japonicum extracts inhibited the adhesion of MDA-MB-231 cells. The invasion of breast cancer cells was suppressed by Erythronium japonicum extracts in a dose-dependent manner. The motility and MMP-2 and MMP-9 activities were also inhibited by both methanol and ethanol extracts. CONCLUSIONS: Our results collectively indicate that Erythronium japonicum extracts inhibit the growth, adhesion, migration and invasion as well as induce the apoptosis of human breast cancer cells. Clinical application of Erythronium japonicum as a potent chemopreventive agent may be helpful in limiting breast cancer invasion and metastasis.

Anti-metastatic and Immunomodulating Activity of Water-Soluble Components from Five Mushroom Extracts

  • Yoo, Hwa-Seung;Han, Sung-Soo;Kim, Jung-sun;Cho, Chong-Kwan;Lee, Yeon-Weol;Park, Sang-Yong;Lee, Soo-Jin
    • 대한한의학회지
    • /
    • 제30권3호
    • /
    • pp.61-69
    • /
    • 2009
  • Objectives : This experiment was conducted to evaluate the inhibitory effects against lung metastasis and promotion of splenocytes by water-soluble components from five mushrooms extracts (WEFM): Garnoderma frondosa, Corious versicolor, Codyceps militaris, Hericium erinaceus and Lentinula edodes. Methods : Colon 26-L5 carcinoma cells were injected through the tail vein to induce lung metastatic cancer. Changes in weight of lung were observed and cytokine level was analyzed to evaluate immunological changes. Results : Oral administration of WEFM resulted in a significant inhibition of lung metastasis after intravenous injection of colon 26-L5 cells in a dose-dependent manner. There was also a significant increase in T cell and B cell mitogenic stimuli and production of IFN-g by splenocytes stimulated with Con A compared to untreated controls. Conclusion : WEFM may have anti-tumor activities via Th1-type dominant immune responses.

  • PDF

Intrahepatic Splenosis Mimicking Liver Metastasis in a Patient with Gastric Cancer

  • Kang, Kyu-Chul;Cho, Gyu-Seok;Chung, Gui-Ae;Kang, Gil-Ho;Kim, Yong-Jin;Lee, Moon-Soo;Kim, Hee-Kyung;Park, Seong-Jin
    • Journal of Gastric Cancer
    • /
    • 제11권1호
    • /
    • pp.64-68
    • /
    • 2011
  • A 54 year old man was referred to our hospital with gastric cancer. The patient had a history of splenectomy and a left nephrectomy as a result of a traffic accident 15 years earlier. The endoscopic findings were advanced gastric cancer at the lower body of the stomach. Abdominal ultrasonography (USG) and magnetic resonance imaging demonstrated a metastatic nodule in the S2 segment of the liver. Eventually, the clinical stage was determined to be cT2cN1cM1 and a radical distal gastrectomy, lateral segmentectomy of the liver were performed. The histopathology findings confirmed the diagnosis of intrahepatic splenosis, omental splenosis. Hepatic splenosis is not rare in patients with a history of splenic trauma or splenectomy. Nevertheless, this is the first report describing a patient with gastric cancer and intrahepatic splenosis that was misinterpreted as a liver metastatic nodule. Intra-operative USG guided fine needle aspiration should be considered to avoid unnecessary liver resections in patients with a suspicious hepatic metastasis.

MiR-150-5p Suppresses Colorectal Cancer Cell Migration and Invasion through Targeting MUC4

  • Wang, Wei-Hua;Chen, Jie;Zhao, Feng;Zhang, Bu-Rong;Yu, Hong-Sheng;Jin, Hai-Ying;Dai, Jin-Hua
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권15호
    • /
    • pp.6269-6273
    • /
    • 2014
  • Growing evidence suggests that miR-150-5p has an important role in regulating genesis of various types of cancer. However, the roles and the underlying mechanisms of miR-150-5p in development of colorectal cancer (CRC) remain largely unknown. Transwell chambers were used to analyze effects on cell migration and invasion by miR-150-5p. Quantitative real-time PCR (qRT-PCR), Western blotting and dual-luciferase 3' UTR reporter assay were carried out to identify the target genes of miR-150-5p. In our research, miR-150-5p suppressed CRC cell migration and invasion, and MUC4 was identified as a direct target gene. Its effects were partly blocked by re-expression of MUC4. In conclusiomn, miR-150-5p may suppress CRC metastasis through directly targeting MUC4, highlighting its potential as a novel agent for the treatment of CRC metastasis.

Gastric Carcinoma with Bone Marrow Metastasis: A Case Series

  • Ekinci, Ahmet Siyar;Bal, Oznur;Ozatli, Tahsin;Turker, Ibrahim;Esbah, Onur;Demirci, Ayse;Budakoglu, Burcin;Arslan, Ulku Yalcintas;Eraslan, Emrah;Oksuzoglu, Berna
    • Journal of Gastric Cancer
    • /
    • 제14권1호
    • /
    • pp.54-57
    • /
    • 2014
  • Gastric cancer is a major cause of cancer-related mortality. At the time of diagnosis, majority of the patients usually have unresectable or metastatic disease. The most common sites of metastases are the liver and the peritoneum, but in the advanced stages, there may be metastases to any region of the body. Bone marrow is an important metastatic site for solid tumors, and the prognosis in such cases is poor. In gastric cancer cases, bone marrow metastasis is usually observed in younger patients and in those with poorly differentiated tumors. Prognosis is worsened owing to the poor histomorphology as well as the occurrence of pancytopenia. The effect of standard chemotherapy is unknown, as survival is limited to a few weeks. This report aimed to evaluate 5 gastric cancer patients with bone marrow metastases to emphasize the importance of this condition.

What are the most important prognostic factors in patients with residual rectal cancer after preoperative chemoradiotherapy?

  • Kim, Sol-Min;Yoon, Ghilsuk;Seo, An Na
    • Journal of Yeungnam Medical Science
    • /
    • 제36권2호
    • /
    • pp.124-135
    • /
    • 2019
  • Background: We aimed to establish robust histoprognostic predictors on residual rectal cancer after preoperative chemoradiotherapy (CRT). Methods: Analyzing known histoprognostic factors in 146 patients with residual disease allows associations with patient outcome to be evaluated. Results: The median follow-up time was 77.8 months, during which 59 patients (40.4%) experienced recurrence and 41 (28.1%) died of rectal cancer. On univariate analysis, residual tumor size, ypT category, ypN category, ypTNM stage, downstage, tumor regression grade, lymphatic invasion, perineural invasion, venous invasion, and circumferential resection margin (CRM) were significantly associated with recurrence free survival (RFS) or/and cancer-specific survival (CSS) (all p<0.005). On multivariate analysis, higher ypTNM stage and CRM positivity were identified as independent prognostic factors for RFS (ypTNM stage, p=0.024; CRM positivity, p<0.001) and CSS (p=0.022, p=0.017, respectively). Furthermore, CRM positivity was an independent predictor of reduced RFS and CSS, irrespective of subgrouping according to downstage (non-downstage, p<0.001 and p<0.001; downstage, p=0.002 and p=0.002) or lymph node metastasis (non-metastasis, p<0.001 and p=0.001; metastasis, p<0.001 and p<0.001). Conclusion: CRM status may be as powerful as ypTNM stage as a prognostic indicator for patient outcome in patients with residual rectal cancer after preoperative CRT.

단일성 안와 골병변으로 확인된 갑상선 여포암의 원격 전이 1예 (A Case of Solitary Metastatic Deposit in the Orbital Rim from Follicular Thyroid Cancer)

  • 전경화;오현석;최인호;변형권
    • 대한두경부종양학회지
    • /
    • 제37권2호
    • /
    • pp.105-109
    • /
    • 2021
  • Follicular thyroid carcinoma (FTC) is the second most common thyroid cancer, following papillary carcinoma. Metastasis to the orbital rim from FTC is very rare. We recently experienced a case of FTC with metastasis to the orbital rim in a 74-year-old woman, who initially presented with a huge thyroid mass and an asymptomatic solitary orbital rim lesion. The solitary orbital rim lesion was suspected to be a separate disease entity such as lymphoma from the preoperative imaging, but bone metastasis from FTC was finally confirmed after orbital rim resection and total thyroidectomy. During follow-up, the patient presented multiple bone metastasis, so the solitary orbital rim lesion was considered a clinical sign of systemic metastasis from FTC. Therefore, we present this unique case with a review of the literature.

양한방 협진을 통한 뇌전이 동반 말기 폐암환자 치험 1례 (Integrated Medicine Therapy for an End-stage Lung Cancer Patient with Brain Metastasis)

  • 박승찬;김도형;한창우;박성하;이인;최준용
    • 대한암한의학회지
    • /
    • 제16권2호
    • /
    • pp.43-51
    • /
    • 2011
  • 이번 증례에서 뇌전이가 동반된 IV기 비소세포성 폐암 환자에 대해 양한방 치료를 병행하여 VAS, FACT-L, FACIT-fatigue 등을 통하여 그 경과를 관찰한 바 방광자극증상 및 수면 등 삶의 질의 개선을 관찰할 수 있었다. 하지만 원활하지 못한 협진 체계로 인하여 환자 관리에 있어 문제점을 발견할 수 있었다. 향후 한방 치료를 통한 암환자 관리를 위해서는 접근성이 뛰어난 양한방 협진체계의 구축이 필수적인 것으로 사료된다.